Page 98 - Inventory Report
P. 98
Revisions Unit Cost Approved Unit Cost Approved Unit Cost Approved Unit Cost Approved $1.29 - revised unit cost Unit Cost Approved Unit Cost Approved $1.9 - revised unit cost $1.29 - revised unit cost
AA
Z $ 1,021,287.64
Extended
Y $ 11.03 $ 11.03 $ 9.15 $ 5.96 $ 4.83 $ 2.58 $ 2.30 $ 2.22 $ 1.90 $ 1.29 $ 1,347.23
Unit
X Cost $ 11.03 $ 11.03 $ 9.15 $ 5.96 $ 4.83 $ 1.29 $ 2.30 $ 2.22 $ 1.90 $ 1.29 $ 64.15
Package Cost
W $ 154.42 $ 154.42 $ 219.59 $ 71.54 $ 115.96 $ 30.96 $ 27.54 $ 26.67 $ 22.80 $ 30.96 $ 64.15
V SOURCE MIS NADAC 6770006039 MIS NADAC/UPD ATED MIS NADAC MIS NADAC/UPD ATED MIS NADAC/UPD ATED 7300005109
U AHFS PREPARATIONS MIS NADAC PREPARATIONS MIS NADAC ANTICOAGULANTS PREPARATIONS PREPARATIONS MIS NADAC 40200000-CALORIC AGENTS PREPARATIONS MIS NADAC 40200000-CALORIC AGENTS 40200000-CALORIC AGENTS 40200000-CALORIC AGENTS GLYCOGENOLYTIC
40120000- REPLACEMENT 40120000- REPLACEMENT 20120400- 40120000- REPLACEMENT 40120000- REPLACEMENT 40120000- REPLACEMENT 68221200-
DEA
T CLAS S
S GENER IC CODE 4290 4290 62660 2840 99573 2840 6931 6960 99573 38585
MANUFACTURER
R Baxter Healthcare Corporation Baxter Healthcare Corporation Fenwal, Inc. B. Braun Medical Inc. Hospira, Inc. B. Braun Medical Inc. B. Braun Medical Inc. B. Braun Medical Inc. B. Braun Medical Inc. B. Braun Medical Inc. Fresenius Kabi USA, LLC
DOSE FORM S INJECTION, S INJECTION, S INJECTION, S INJECTION, S INJECTION, S INJECTION,
Q INTRAVENOU SOLUTION INTRAVENOU SOLUTION INTRAVENOU S SOLUTION INTRAVENOU S INJECTION INTRAVENOU SOLUTION INTRAVENOU S SOLUTION INTRAVENOU SOLUTION INTRAVENOU SOLUTION INTRAVENOU SOLUTION INTRAVENOU S SOLUTION KIT
SIZE
P TXT 14X100 0 14X100 0 12X100 0 24X500 ML 24X500 ML 12X100 0 12X100 0 12X100 0 24X500 ML 1 EA
UOI
O SIZE
PACK AGE 1000 1000 500 1000 500 500 1000 1000 1000 500 1
N SIZE
M STRENG TH 526; 502; 368; 37; 30mg/100 mL; mg/100m L; L; mg/100m L; 526; 502; 368; 37; 30mg/100 mL; mg/100m L; L; mg/100m L; 12.25; 11; 3.65g/500 mL; g/500mL; g/500mL .075g/100 mL; g/100mL; g/100mL 600; 310; 30; 20mg/100 mL; L; mg/100m L; 10g/100m L .6; .31; .03; .02g/100 g/100mL; g/100mL; g/100mL 5; .9g/100m L; 5; .2g/100m L; 10g/100m L 1MG
L GENERIC SODIUM CHLORIDE; SODIUM GLUCONAT E; SODIUM ACETATE; POTASSIUM mg/100m CHLORIDE; MAGNESIU M SODIUM CHLORIDE; SODIUM GLUCONAT E; SODIUM ACETATE; POTASSIUM mg/100m CHLORIDE; MAGNESIU M DEXTROSE MONOHYD RATE; SODIUM CITRATE DIHYDRATE ; POTASSIUM POTASSIUM 5; .45; CHLORIDE; DEXTROSE; SODIUM CHLORIDE SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM mg/100m CHLORIDE; CALCIUM CHLORIDE DEXTROSE MONOHYD RATE SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM mL; CHLORIDE; CALCIUM CHLORIDE DEXTROSE; SODIUM CHLORIDE DEXTROSE; SODIUM CHLORIDE DEXTROSE MONOHYD RATE GLUCAGON
K TRADE PLASMA- LYTE A PLASMA- LYTE A ACD FORMULA A Anticoagulan t Citrate Dextrose CHLORIDE IN DEXTROSE AND LACTATED RINGER'S DEXTROSE LACTATED RINGER'S DEXTROSE AND SODIUM DEXTROSE AND SODIUM DEXTROSE GLUCAGON
J MERIDIAN DESC PLASMA-LYTE A PH 1000 PLASMA-LYTE A PH 1000 ACD-A SOLUTION 500 DEXTROSE 5%-1/2NS- KCL IV SOLN L6340 1000 LACTATED RINGERS IV SOLN 500 DEXTROSE/WATER DEXTROSE IN WATER DEHP FR BG L5201 500 LACTATED RINGERS IV SOLN L7500 1000 DEXTROSE 5%-0.9% NACL IV SOLN L6100 1000 DEXTROSE 5%-0.2% NACL IV SOLN L6160 1000 DEXTROSE/WATER DEXTROSE IN WATER DEHP FR BG L5201 500 GLUCAGON HCL VIAL 1 MG 1
Med Desc IVSL 14X1000 IVSL 14X1000 ACD-A 500ML CONT CS24 4B7898Q DEX 5%-1/2NS-KCL 10MEQ/L 12X1L LACTATED RINGERS 24X500ML LF 10% 24X500ML LACTATED RINGERS 12X1000ML EXC 0.9% 12X1L EXC 0.2% 12X1L EXC 10% 24X500ML Glucagon 1mg PWVL 1 EA
I Plasma-Lyte A Ph7.4 7.4 IV SOLN 2B2544 Plasma-Lyte A Ph7.4 7.4 IV SOLN 2B2544 DEXTROSE/NACL 5- DEXTROSE/NACL 5-
Alert
H
1 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991